检索结果-南通市图书馆

Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children

在线全文

学校读者我要写书评

暂无评论

Infectious Diseases & Immunity 2024年第3期4卷 106-120页

作者： chinese Society of Infectious Diseases chinese Medical Association chinese Society of Hepatology chinese Medical Association Group of Infectious Diseases chinese Pediatric Society chinese Medical Association National Clinical Research Center for Infectious Diseases(beijing) Fu-Sheng Wang Shishu Zhu Min Zhang Jianshe Wang Shuangjie Li Junliang Fu Yuanyuan Li Yuming Guo Jing Li Hongmei Xu Wenxian Ouyang Yuemin Nan Sainan Shu Shuangsuo Dang Xiaoyuan Xu Taisheng Li Jinlin Hou 不详 The Fifth Medical Center of PLA General Hospital Beijing 100039China Fudan university Children’s Hospital Hunan Children’s Hospital Children’s Hospital of Chongqing Medical university Third Hospital Hebei Medical University Tongji Hospital Tongji Medical CollegeHuazhong University of Science and Technology The Second Affiliated Hospital of Xi’an Jiaotong university Peking university First Hospital Peking Union Medical College Hospital Chinese Academy of Medical Sciences&Peking Union Medical College Nanfang Hospital Southern Medical University

The aim of this consensus is to standardize the prevention, diagnosis, and treatment of chronic hepatitis B in children and to achieve the goal of “eliminating viral hepatitis as a major public health threat by 2.30” issued by the World Health Organization. Formulated by organized experts of the chinese Society of Infectious Diseases and chinese Society of Hepatology, chinese Medical Association;Group of Infectious Diseases, chinese Pediatric Society, chinese Medical Association;and the National Clinical Research Center for Infectious Diseases (beijing), the consensus provides the latest evidence and recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B in children.

关键词： Chronic hepatitis B Children Treatment Prevention Consensus

chinese expert consensus on the clinical application of sodium-glucose cotransporter 2.inhibitors in patients with chronic kidney disease

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

chinese Medical Journal 2024年第11期137卷 1264-1266页

作者： The Expert Group of chinese Expert Consensus on the Clinical Application of Sodium-glucose Cotransporter 2.Inhibitors in Patients with Chronic Kidney Disease Fan Fan Hou Chuanming Hao Min Zhang Chuanming Hao 不详 Department of Nephrology Nanfang HospitalSouthern Medical UniversityGuangzhouGuangdong 510515China Division of Nephrology Huashan HospitalFudan UniversityShanghai 200040China

The prevalence of chronic kidney disease(CKD)in China was 8.2.in 2.18-2.19.[1]CKD may progress to end-stage kidney disease(ESKD),necessitating kidney replacement treatment such as dialysis or kidney transplantation,[2.which imposes a substantial burden on both family and ***,patients with CKD have a high risk of comorbidities including cardiovascular diseases.[3]The risk of death rises as the estimated glomerularltration rate(eGFR)declines.[3]A substantial portion of CKD patients die,primarily from cardiovascular events,before reaching the stage requiring dialysis.[3]As such,delaying the progression of CKD and reducing cardiovascular events are key elements in patient *** recent years,important progress has been made in the cardiorenal protection of patients with ***cally,the advent of sodium-glucose cotransporter 2.SGLT2.inhibitors has provided a new and important approach for the treatment of CKD.

关键词： kidney patients dialysis

chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation

在线全文

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第3期21卷 251-314页

作者： Chang-Sheng MA Shu-Lin WU Shao-Wen LIU Ya-Ling HAN chinese Society of Cardiology chinese Medical Association Heart Rhythm Committee of chinese Society of Biomedical Engineering beijing Anzhen Hospital Capital Medical University Guandong Provincial People’s Hospital Shanghai First People’s Hospital General Hospital of Northern Theater Command 不详

Atrial fibrillation(AF)is the most common sustained cardiac arrhythmia,significantly impacting patients’quality of life and increasing the risk of death,stroke,heart failure,and *** the past two decades,there have been significant breakthroughs in AF risk prediction and screening,stroke prevention,rhythm control,catheter ablation,and integrated *** this period,the scale,quality,and experience of AF management in China have greatly improved,providing a solid foundation for the development of guidelines for the diagnosis and management of *** further promote standardized AF management,and apply new technologies and concepts to clinical practice in a timely and comprehensive manner,the chinese Society of Cardiology of the chinese Medical Association and the Heart Rhythm Committee of the chinese Society of Biomedical Engineering have jointly developed the chinese Guidelines for the Diagnosis and Management of Atrial *** guidelines have comprehensively elaborated on various aspects of AF management and proposed the CHA2.S2.VASc-60 stroke risk score based on the characteristics of AF in the Asian *** guidelines have also reevaluated the clinical application of AF screening,emphasized the significance of early rhythm control,and highlighted the central role of catheter ablation in rhythm control.

关键词： prevention sustained diagnosis

chinese national clinical practice guidelines on the prevention,diagnosis,and treatment of early gastric cancer

在线全文

学校读者我要写书评

暂无评论

chinese Medical Journal 2024年第8期137卷 887-908页

作者： Peng Li Ziyu Li Enqiang Linghu Jiafu Ji Society of Digestive Endoscopy of the chinese Medical Association Colorectal Surgery Group of the chinese Medical Association chinese Association of Gastroenterologists&Hepatologists National Clinical Research Center for Digestive Diseases chinese Medical Journal Clinical Practice Guideline Collaborative Department of Gastroenterology Beijing Friendship HospitalCapital Medical UniversityNational Clinical Research Center for Digestive DiseaseBeijing 100050China Department of Gastrointestinal Surgery Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education)Peking University Cancer Hospital and InstituteBeijing 100142China Department of Gastroenterology and Hepatology the First Medical CenterChinese People’s Liberation Army General HospitalBeijing 100853China 不详

Background:Gastric cancer is one of the most common malignant tumors in the digestive system in *** comprehensive practice guidelines for early gastric cancer in China are currently ***,we created the chinese national clinical practice guideline for the prevention,diagnosis,and treatment of early gastric ***:This clinical practice guideline(CPG)was developed in accordance with the World Health Organization’s recommended process and with the Grading of Recommendations Assessment,Development,and Evaluation(GRADE)in assessing evidence *** used the Evidence to Decision framework to formulate clinical recommendations to minimize bias and increase transparency in the CPG development *** used the Reporting Items for practice Guidelines in HealThcare(RIGHT)statement and the Appraisal of Guidelines for Research and Evaluation II(AGREE II)as reporting and conduct guidelines to ensure completeness and transparency of the ***:This CPG contains 40 recommendations regarding the prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer based on available clinical studies and *** provide recommendations for the timing of Helicobacter pylori eradication,screening populations for early gastric cancer,indications for endoscopic resection and surgical gastrectomy,follow-up interval after treatment,and other ***:This CPG can lead to optimum care for patients and populations by providing up-to-date medical *** intend this CPG for widespread adoption to increase the standard of prevention,screening,diagnosis,treatment,and follow-up of early gastric cancer;thereby,contributing to improving national health care and patient quality of life.

关键词： Early gastric cancer Prevention Screening Diagnosis Treatment Follow-up

chinese Expert Consensus on Microvascular Protection Strategy During Emergency Percutaneous Coronary Intervention Therapy in Patients With ST-elevation Myocardial Infarction

在线全文

学校读者我要写书评

暂无评论

Cardiology Discovery 2024年第1期4卷 5-14页

作者： chinese Society of Cardiology,chinese Medical Association Editorial Board of chinese Journal of Cardiology Muwei Li Yabin Wang Yaling Han Yun Zhang Feng Cao 不详 Fuwai Central China Cardiovascular Hospital chinese People’s Liberation Army General Hospital General Hospital of Northern Theater Command Qilu Hospital of Shandong university

Microcirculatory dysfunction(CMD)typically occurs in patients with acute ST-segment elevation myocardial infarction during percutaneous coronary intervention,which is associated with more severe myocardial injury and a worse *** the advancement of intracoronary physiology and imaging technology,the prevention and therapeutic interventions of CMD have attracted more ***,relevant guidelines or consensus on CMD are lacking in *** current consensus summarizes the prevention and diagnostic strategies of emergency percutaneous coronary intervention-related CMD and gives suggestions to improve the prognosis of ST-segment elevation myocardial infarction patients based on evidence from recent clinical studies,guidelines,and consensus from international sources.

关键词： Myocardial infarction Microcirculation dysfunction Percutaneous coronary intervention

chinese expert consensus on immunotherapy for advanced non-small cell lung cancer with oncogenic driver mutations(2.2. edition)

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

chinese Medical Journal 2024年第9期137卷 1016-1018页

作者： The Society of Cancer Precision Medicine of chinese Anti-Cancer Association The Lung Cancer Expert Group of chinese Medical Association Publishing House Baohui Han Hua Zhong 不详 Department of Respiratory Medicine Shanghai Chest HospitalSchool of MedicineShanghai JiaoTong UniversityShanghai 20030China Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine

Non-small cell lung cancer(NSCLC)with oncogenic driver mutations was previously deemed“forbidden territory”for immunotherapy.[1]With the continuous generation of evidence,immunotherapy is expected to bring hope for such NSCLC with oncogenic driver mutations after acquired tyrosine kinase inhibitor(TKI)***,given the intricate interplay between driven mutations,targeted therapy,and immune microenvironment,the efcacy of immunotherapy in advanced NSCLC patients with diverse oncogenic driver mutations remains a topic of ongoing *** this context,chinese Expert Consensus on Immunotherapy for Advanced NSCLC with Oncogenic Driver Mutations(2.2. edition)wasrst launched in 2.2. by the Society of Cancer Precision Medicine of chinese Anti-Cancer Association and the Lung Cancer Expert Group of chinese Medical Journals,aiming to provide standardized treatment guidance for clinical practice.

关键词： immunotherapy cancer lung

2.2. Guideline for the management of hypertension in the elderly population in China

在线全文

学校读者我要写书评

暂无评论

Journal of Geriatric Cardiology 2024年第6期21卷 589-630页

作者： Hypertension Branch of chinese Geriatrics Society,beijing Hypertension Association,National Clinical Research Center of the Geriatric Diseases Qi HUA Li FAN Zeng-Wu WANG Jing LI 不详 Xuanwu Hospital Capital Medical UniversityBeijingChina chinese PLA General Hospital BeijingChina Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina

Preamble Hypertension is one of the most common chronic diseases and the primary risk factor for stroke,myocardial infarction and even cardiovascular *** than half of the elderly population has high blood *** people are a unique group,and strategies for the prevention,diagnosis,evaluation,and treatment of hypertension in elderly individuals differ significantly from those in the general population.

关键词： hypertension prevention diagnosis

chinese expert consensus statement on the diagnosis and treatment of Hirschsprung disease

在线全文

学校读者我要写书评

暂无评论

chinese Medical Journal 2024年第5期137卷 505-507页

作者： Tianqi Zhu Weibing Tang Jiexiong Feng the chinese Research Group of Hirschsprung Disease Department of Pediatric Surgery Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyHubei Clinical Center of Hirschsprung’s Disease and Allied DisordersWuhanHubei 430030China Department of Neonatal Surgery Children’s Hospital of Nanjing Medical UniversityNanjingJiangsu 210008China 不详

Hirschsprung disease(HSCR)is a congenital anomaly of the intestine caused by the developmental absence of the enteric nervous system,which results in variable lengths of intestinal dysfunction and requires surgical intervention.^([1])Due to the complex etiology,multiple surgical procedures and postoperative complications,the diagnosis and treatment strategies of HSCR have always been the focus of pediatric surgeons around the *** pediatric surgical experts with rich clinical experience from almost all national and provincial children’s medical centers in China constituted the chinese Research Group of Hirschsprung disease(CRGHSCR).

关键词： diagnosis intestine treatment

The features of gravity field and deep structure in western part of the South Yellow Sea

在线全文

学校读者我要写书评

暂无评论

chinese Science Bulletin 2000年第8期45卷 759-764页

作者： WANG Qianshen1 & AN Yulin1. Institute of Geophysics, chinese Academy of Sciences, beijing 100101, China {2., beijing 100083, China Institute of Geophysics Chinesc Academy of Sciences Beijing China chinese university of {2. Beijing China

The gravity data from the sea region to the west of 12.° E of the South Yellow Sea have been processed and the feature of gravity fields analyzed. An experience relationship formula on the filter wavelength and corresponding depth has been put forward. Combined with the geological and seismic data, the deep tectonic framework and structural characters as well as possible favourable prospecting district for hydrocarbon in the South Yellow Sea have been discussed and analyzed.

关键词： western part of the South Yellow Sea gravity field deep structure.